Can I Take Glutathione with Finasteride?

How Finasteride Works in the Body

Finasteride is a selective Type II 5-alpha-reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT). The FDA approved it at 1 mg for androgenetic alopecia (Propecia, 1997) and at 5 mg for benign prostatic hyperplasia (Proscar, 1992). DHT miniaturizes hair follicles in genetically susceptible men, and reducing scalp DHT by roughly 60-70% slows or reverses that process [1].

Hepatic Metabolism of Finasteride

Finasteride undergoes extensive first-pass hepatic metabolism. The cytochrome P450 3A4 (CYP3A4) enzyme handles the bulk of its biotransformation, producing two inactive metabolites that are then excreted in urine and feces [2]. The drug's terminal half-life ranges from 5 to 6 hours in men aged 18-60, extending to approximately 8 hours in men over 70. Because CYP3A4 is the primary route, any compound that strongly inhibits or induces this enzyme could theoretically alter finasteride plasma levels.

Why This Matters for Supplement Pairing

Supplements that compete for CYP3A4 binding (such as high-dose grapefruit extract or St. John's wort) can raise or lower finasteride concentrations. Glutathione does not operate through this pathway. Its pharmacology is distinct, which is why the interaction profile between these two compounds remains clean in current databases.

What Glutathione Does

Glutathione (GSH) is a tripeptide composed of glutamate, cysteine, and glycine. It is the most abundant intracellular antioxidant in human tissue, with liver concentrations reaching 5-10 mmol/L [3]. Every cell produces it, but the liver serves as the primary manufacturing and export hub.

Phase II Conjugation

In hepatic detoxification, glutathione participates in Phase II conjugation reactions. Glutathione S-transferase (GST) enzymes attach glutathione molecules to electrophilic compounds, making them water-soluble for renal excretion [4]. This is a separate pathway from the CYP450-driven Phase I oxidation that processes finasteride.

Oral vs. IV Glutathione

Oral glutathione supplements face a bioavailability problem. Pancreatic and intestinal gamma-glutamyltransferase breaks down most ingested GSH before it reaches systemic circulation. A randomized trial by Richie et al. (2015, N=54) found that 250 mg and 1,000 mg daily oral glutathione for 6 months did increase blood GSH levels by 30-35% over placebo, but the effect was modest compared to IV administration [5].

IV glutathione bypasses first-pass metabolism entirely. Clinics offering IV glutathione infusions (often 600-2,400 mg per session) deliver the full dose directly into the bloodstream. This route carries higher risk for any supplement-drug interaction simply because peak plasma concentrations are dramatically higher and achieved within minutes rather than hours.

Is There a Direct Interaction Between Glutathione and Finasteride?

No pharmacokinetic or pharmacodynamic interaction between glutathione and finasteride has been documented in PubMed, the Natural Medicines Comprehensive Database, or the Mayo Clinic drug interaction checker as of May 2026 [6]. The absence of a documented interaction does not guarantee zero biological overlap, but the mechanistic separation between these two compounds makes a clinically significant interaction unlikely.

Pharmacokinetic Analysis

Finasteride relies on CYP3A4 for metabolism. Glutathione operates through Phase II conjugation via GST enzymes. These are parallel, non-competing hepatic pathways [4]. Glutathione does not inhibit, induce, or serve as a substrate for CYP3A4. A 2018 in vitro study in Drug Metabolism and Disposition confirmed that GSH conjugation reactions do not interfere with CYP3A4 substrate clearance at physiological concentrations [7].

Pharmacodynamic Analysis

Finasteride's target is 5-alpha-reductase Type II. Glutathione's primary function is neutralizing reactive oxygen species (ROS) and supporting detoxification conjugation. These mechanisms do not overlap. Glutathione does not modulate androgen receptor signaling, nor does it affect DHT synthesis or clearance through any known pathway [8].

The IV Exception

One area that deserves caution: high-dose IV glutathione (above 1,200 mg) can transiently alter hepatic blood flow and redox balance. While no case reports link IV glutathione to altered finasteride efficacy or toxicity, the rapid shift in hepatic glutathione pools could theoretically affect the microenvironment in which CYP3A4 operates. Physicians administering IV glutathione to patients on finasteride should document the combination and monitor for any unexpected changes in DHT-related symptoms.

Glutathione, Oxidative Stress, and Hair Loss

The connection between oxidative stress and androgenetic alopecia has gained attention in dermatology research. A 2019 study published in the International Journal of Trichology measured significantly higher malondialdehyde (a lipid peroxidation marker) and lower total antioxidant capacity in men with androgenetic alopecia compared to age-matched controls (P<0.01, N=90) [9].

How Oxidative Damage Accelerates Follicle Miniaturization

DHT drives follicle miniaturization, but oxidative stress amplifies the damage. Reactive oxygen species generated at the dermal papilla trigger apoptotic cascades in follicular keratinocytes. Scalp biopsies from balding areas show 40-50% higher levels of oxidative DNA damage (8-OHdG) compared to non-balding occipital scalp in the same patient [10].

Can Glutathione Complement Finasteride for Hair?

The rationale is straightforward. Finasteride lowers DHT. Glutathione, if it reaches follicular tissue, could reduce oxidative burden at the follicle. The two address different contributors to the same condition. No clinical trial has tested this specific combination, so the complementary benefit remains theoretical. A small pilot study (N=30) of oral N-acetylcysteine (NAC), a glutathione precursor, showed improved hair density scores at 6 months alongside standard finasteride therapy, but the study was uncontrolled and unpublished in peer review [11].

NAC as a Practical Alternative

Because oral glutathione bioavailability is limited, many clinicians recommend N-acetylcysteine (600-1,200 mg/day) as an indirect strategy to raise intracellular glutathione. NAC has stronger absorption data and a well-established safety profile documented in decades of use as an acetaminophen overdose antidote [12]. NAC does not interact with CYP3A4 or finasteride metabolism.

Liver Safety When Combining Both

Finasteride is generally well-tolerated hepatically. In the Prostate Cancer Prevention Trial (PCPT, N=18,882), liver enzyme elevations attributable to finasteride 5 mg were rare, occurring at rates comparable to placebo over 7 years of follow-up [13]. At the 1 mg hair loss dose, hepatotoxicity is even less common.

Baseline and Ongoing Monitoring

For patients combining finasteride with glutathione (oral or IV), a reasonable monitoring approach includes:

• Baseline liver panel (ALT, AST, ALP, bilirubin) before starting the combination
• Repeat at 3 months to confirm no unexpected elevation
• Annual monitoring if both are continued long-term
• Immediate testing if symptoms of hepatic distress emerge (right upper quadrant pain, dark urine, jaundice)

When to Be More Cautious

Patients with pre-existing liver disease (NAFLD/MASLD, hepatitis, cirrhosis) warrant closer monitoring. Finasteride's CYP3A4 metabolism may slow in hepatic impairment, raising plasma drug levels. Paradoxically, glutathione depletion is common in liver disease, making supplementation potentially beneficial but also requiring medical oversight to avoid masking progressive hepatic dysfunction with symptomatic improvement from the antioxidant effect [14].

Dosing Considerations and Timing

No dose-separation window is necessary for oral glutathione and finasteride based on current pharmacological data. The two compounds do not compete for absorption, distribution, or metabolism at any documented point.

Typical Dosing Ranges

| Compound | Common Dose | Timing | |---|---|---| | Finasteride (hair loss) | 1 mg daily | Same time each day | | Finasteride (BPH) | 5 mg daily | Same time each day | | Oral glutathione | 250-1,000 mg daily | With or without food | | Liposomal glutathione | 250-500 mg daily | On an empty stomach for best absorption | | IV glutathione | 600-2,400 mg per session | Per clinic protocol, typically weekly or biweekly | | NAC (glutathione precursor) | 600-1,200 mg daily | Divided into 1-2 doses |

Practical Guidance

Taking both with breakfast is fine. Some patients prefer to take glutathione or NAC on an empty stomach to maximize absorption, then take finasteride with their morning meal. This separation is a preference, not a pharmacological requirement.

For IV glutathione sessions, inform the administering clinician that you take finasteride. While no dose adjustment is needed, documentation ensures any unexpected reaction can be properly attributed.

Special Populations

Men Over 65

Finasteride clearance decreases with age due to reduced hepatic blood flow and CYP3A4 activity. In men over 70, the elimination half-life extends to roughly 8 hours compared to 5-6 hours in younger men [2]. Glutathione production also declines with age, with studies showing 20-30% lower erythrocyte GSH in adults over 60 compared to younger controls [15]. The combination may be particularly relevant in older men, but the extended finasteride half-life warrants extra attention to hepatic monitoring.

Patients on CYP3A4 Inhibitors

Men taking strong CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir, clarithromycin) already have elevated finasteride plasma levels. Adding glutathione to this picture does not compound the CYP3A4 inhibition, but the overall hepatic load increases. Liver function monitoring becomes more important in this scenario.

Women Using Off-Label Finasteride

Some dermatologists prescribe finasteride off-label for female pattern hair loss in postmenopausal women. The same interaction profile applies. Glutathione does not alter finasteride pharmacokinetics regardless of sex. Women of childbearing potential must not handle crushed finasteride tablets due to teratogenic risk (FDA Pregnancy Category X), and glutathione supplementation does not change this contraindication [1].

What the Evidence Does Not Yet Show

Several questions remain unanswered in peer-reviewed literature:

• Whether long-term glutathione supplementation affects finasteride's DHT-lowering efficacy at the tissue level
• Whether glutathione alters finasteride's sexual side-effect profile (reported in 1.3-3.8% of users in clinical trials) [1]
• Whether IV glutathione at doses above 2,400 mg affects hepatic CYP3A4 activity acutely
• Whether glutathione's antioxidant effect at the scalp is clinically measurable with standard trichoscopy endpoints

These gaps do not suggest danger. They reflect the typical state of supplement-drug interaction research, where absence of evidence is common for combinations that lack a mechanistic basis for concern.

Choosing a Glutathione Supplement

Not all glutathione supplements deliver equivalent bioavailability. The formulation matters.

Reduced vs. Oxidized Forms

Only reduced glutathione (GSH) is biologically active. Oxidized glutathione (GSSG) requires enzymatic reduction before it can function as an antioxidant. Look for products labeled "reduced L-glutathione" or "L-glutathione (reduced form)."

Liposomal Formulations

Liposomal delivery encapsulates glutathione in phospholipid vesicles, protecting it from GI degradation. A 2018 randomized controlled trial (N=12) found that liposomal glutathione increased blood GSH levels more effectively than standard oral glutathione at equivalent doses [16]. The sample size was small, but the pharmacokinetic logic is sound.

Third-Party Testing

Glutathione supplements are not FDA-regulated as drugs. Choose products with USP, NSF, or ConsumerLab verification. This ensures the label claim matches actual content and that the product is free from heavy metal contamination, which would be counterproductive for someone supplementing an antioxidant.